Fantegrossi William E, Ullrich Thomas, Rice Kenner C, Woods James H, Winger Gail
Department of Psychology (Biopsychology Program), University of Michigan, Ann Arbor, MI 48109-1109, USA.
Psychopharmacology (Berl). 2002 Jun;161(4):356-64. doi: 10.1007/s00213-002-1021-6. Epub 2002 Apr 19.
The reinforcing effects of MDMA and its enantiomers have not been extensively characterized in laboratory animals.
To investigate whether MDMA and its stereoisomers would be self-administered intravenously by rhesus monkeys ( Macaca mulatta), and to assess the effects of serotonin(2) receptor antagonists on MDMA-maintained responding.
Four adult male rhesus monkeys were maintained on a fixed ratio 10, time-out 60-s schedule for 0.01 mg/kg cocaine or saline injections. Racemic MDMA and its stereoisomers, and racemic methamphetamine were periodically substituted for cocaine or saline. In subsequent antagonist experiments, five adult rhesus monkeys (three male, two female) were maintained on a multiple dose fixed ratio 30, time-out 45-s schedule for cocaine or saline injections. Racemic MDMA and its enantiomers were periodically substituted for cocaine or saline, with or without a pre-session injection of the serotonin(2) receptor antagonists ketanserin or MDL100907.
In the initial self-administration experiments, MDMA and its stereoisomers generated "inverted U"-shaped self-administration curves across the dose range tested. Racemic MDMA doses between 0.01 and 0.1 mg/kg per injection, S(+)-MDMA doses between 0.003 and 0.1 mg/kg per injection, and R(-)-MDMA doses between 0.01 and 0.1 mg/kg per injection engendered more responding than saline; however, no dose of any form of MDMA maintained as much behavior as cocaine or methamphetamine. In subsequent antagonist experiments, pretreatments with 0.1 or 0.3 mg/kg ketanserin or MDL100907 attenuated responding for S(+)-MDMA, and completely abolished responding for R(-)-MDMA, but did not affect cocaine-maintained behavior.
MDMA and its stereoisomers serve as reinforcers in rhesus monkeys. We suggest that stimulation of 5-HT(2A) receptors is integral to the reinforcing effects of MDMA.
3,4-亚甲基二氧甲基苯丙胺(MDMA)及其对映体的强化作用在实验动物中尚未得到广泛研究。
研究MDMA及其立体异构体是否会被恒河猴静脉自身给药,并评估5-羟色胺(2)受体拮抗剂对MDMA维持反应的影响。
四只成年雄性恒河猴按照固定比例10、60秒超时的时间表,接受0.01mg/kg可卡因或生理盐水注射。外消旋MDMA及其立体异构体,以及外消旋甲基苯丙胺会定期替代可卡因或生理盐水。在随后的拮抗剂实验中,五只成年恒河猴(三只雄性,两只雌性)按照多剂量固定比例30、45秒超时的时间表,接受可卡因或生理盐水注射。外消旋MDMA及其对映体会定期替代可卡因或生理盐水,同时会在实验前注射5-羟色胺(2)受体拮抗剂酮色林或MDL100907,或不注射。
在最初的自身给药实验中,MDMA及其立体异构体在测试的剂量范围内产生了“倒U形”自身给药曲线。每次注射0.01至0.1mg/kg的外消旋MDMA剂量、每次注射0.003至0.1mg/kg的S(+)-MDMA剂量,以及每次注射0.01至0.1mg/kg的R(-)-MDMA剂量,比生理盐水引发了更多的反应;然而,任何形式的MDMA都没有一个剂量能维持与可卡因或甲基苯丙胺一样多的行为。在随后的拮抗剂实验中,用0.1或0.3mg/kg的酮色林或MDL100907预处理会减弱对S(+)-MDMA的反应,并完全消除对R(-)-MDMA的反应,但不影响可卡因维持的行为。
MDMA及其立体异构体在恒河猴中起到强化物的作用。我们认为,5-羟色胺(2A)受体的刺激对于MDMA的强化作用不可或缺。